Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 1057
Journal of Molecular Pharmaceutics & Organic Process Research peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Academic Keys
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Share This Page
Biopharmaceuticals
Biopharmaceuticals are a rapidly evolving class of therapeutic agents derived from biological sources, including proteins, nucleic acids, and cells. Unlike traditional pharmaceuticals, which are typically chemically synthesized, biopharmaceuticals are produced using biotechnological methods such as recombinant DNA technology and cell culture. These drugs include monoclonal antibodies, vaccines, therapeutic proteins (like insulin and growth hormones), and gene therapies. Biopharmaceuticals offer targeted treatment options, often with fewer side effects compared to conventional drugs. They play a crucial role in treating complex diseases such as cancer, autoimmune disorders, and rare genetic conditions. The field is continually advancing with innovations in biologics and personalized medicine, promising more effective and individualized treatment strategies.
Biopharmaceuticals
Speaker PPTs
- Ricardo Ibarra-Cabrera
Business and regulatory environment of biopharmaceuticals and biosimilars in Latin America
PPT Version | PDF Version